drugset / Trial / NCT00177424

Sertraline for Preventing Post-stroke Depression and Improving Rehabilitation Outcomes

NCT00177424

RandomizedParallel-groupQuadruple-blindPrevention

Summary

This study will determine the effectiveness of sertraline administration after a stroke in preventing the onset of post-stroke depression.

Timeline

Start
2004-07
Primary completion
2007-10
Completion
2007-10

Drugs

EvaluationDrugModalityDoseRoute
Comparator Sertraline Small molecule 75 mg